Immix Biopharma, Inc.
IMMX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $67 | $62 | $50 | $61 |
| - Cash | $16 | $12 | $16 | $18 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $52 | $51 | $35 | $44 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$7 | -$5 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$7 | -$5 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | -0.22 | -0.15 | -0.17 |
| % Growth | -9.1% | -46.7% | 11.8% | – |
| Operating Cash Flow | -$6 | -$5 | -$2 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$6 | -$5 | -$2 | -$2 |